Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 56 entries
View as:

Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01190878 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

Phase: N/A Priority: Normal
NCT ID: NCT06336603 Org: User:
Start: 11/15/23 End: 10/29/24 Due: 10/29/25

Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%

Phase: N/A Priority: Normal
NCT ID: NCT03212963 Org: User:
Start: 03/21/17 End: 08/12/19 Due: 08/12/20

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Phase: N/A Priority: Normal
NCT ID: NCT03552276 Org: User:
Start: 07/11/18 End: 09/18/23 Due: 09/18/24

Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01543490 Org: User:
Start: 03/30/18 End: 02/04/20 Due: 02/04/21

Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab

Phase: N/A Priority: Normal
NCT ID: NCT03992729 Org: User:
Start: 08/29/19 End: 12/01/25 Due: 12/01/26

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03718299 Org: User:
Start: 07/16/19 End: 11/05/21 Due: 11/05/22

A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05022004 Org: User:
Start: 12/20/21 End: 01/06/23 Due: 01/06/24

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)

Phase: N/A Priority: Normal
NCT ID: NCT01729754 Org: User:
Start: 02/05/13 End: 10/26/21 Due: 10/26/22

Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT04506463 Org: User:
Start: 12/22/20 End: 08/10/22 Due: 08/10/23

A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Phase: N/A Priority: Normal
NCT ID: NCT06611163 Org: User:
Start: 03/21/25 End: 01/31/28 Due: 01/31/29

Bio-equivalence Study Between SAPHRIS and Asenapine

Phase: N/A Priority: Normal
NCT ID: NCT01948024 Org: User:
Start: 07/31/13 End: 08/31/13 Due: 08/31/14

Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01387464 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01753102 Org: User:
Start: 11/06/12 End: 04/30/13 Due: 04/30/14

A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

Phase: N/A Priority: Normal
NCT ID: NCT06425900 Org: User:
Start: 07/01/24 End: 09/30/25 Due: 09/30/26

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Phase: N/A Priority: Normal
NCT ID: NCT04314544 Org: User:
Start: 07/01/20 End: 05/31/26 Due: 05/31/27

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03298581 Org: User:
Start: 01/01/17 End: 01/31/18 Due: 01/31/19

Efficacy and Safety Study of SUNPG1623

Phase: N/A Priority: Normal
NCT ID: NCT02980692 Org: User:
Start: 04/19/17 End: 09/24/19 Due: 09/24/20

Pharmacokinetic and Pharmacodynamic Study of Cyclofem

Phase: N/A Priority: Normal
NCT ID: NCT01699022 Org: User:
Start: 06/30/10 End: 12/31/11 Due: 12/31/12

Efficacy and Safety Study of SUNPG1622

Phase: N/A Priority: Normal
NCT ID: NCT02980705 Org: User:
Start: 11/06/17 End: 09/03/19 Due: 09/03/20

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03897075 Org: User:
Start: 05/13/21 End: 01/30/25 Due: 01/30/26

2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03192150 Org: User:
Start: 01/03/18 End: 11/18/19 Due: 11/18/20

A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne

Phase: N/A Priority: Normal
NCT ID: NCT06415305 Org: User:
Start: 09/01/23 End: 01/30/25 Due: 01/30/26

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00578955 Org: User:
Start: 12/31/07 End: 10/31/08 Due: 10/31/09

Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility

Phase: N/A Priority: Normal
NCT ID: NCT00610077 Org: User:
Start: 12/31/04 End: 07/31/06 Due: 07/31/07